In conclusion, elevated levels of VAP-1 protein in gliomas constitute a highly aggressive subgroup associated with poor outcomes, and VAP-1 co-expressed with TAM CD163 subtype is shown to be an excellent prognostic indicator for glioma patients. This evidence concerns the gene AOC3 and glioma.